Neonates exposed to HIV but uninfected exhibit an altered gut microbiota and inflammation associated with impaired breast milk antibody functionOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study investigated the neonatal gut bacterial and viral microbiome in infants exposed to HIV but who remained uninfected, and examined how this exposure relates to inflammatory biomarkers in plasma. The researchers also tested whether HIV exposure alters antibody-microbiota binding in the neonatal gut. Finally, they assessed whether antibodies present in breast milk affect the growth of commensal gut bacteria.
Who was studied?
The study compared neonates exposed to HIV but uninfected (nHEU) with unexposed, uninfected neonates (nHU). Breast milk from mothers living with HIV was also analyzed and compared for its antibody function. The abstract does not give specific sample sizes, so the exact cohort size cannot be stated.
What were the most important findings?
Neonates exposed to HIV but uninfected showed an altered gut bacteriome and a milder change in the enteric DNA virome compared to unexposed neonates. HIV exposure also differentially affected IgA binding to gut microbiota. The relative abundance of Blautia spp., in both whole stool and IgA-bound microbiota, was positively associated with plasma C-reactive protein levels. Breast milk IgA from mothers living with HIV showed a significantly reduced ability to inhibit the growth of Blautia coccoides, and this reduced inhibitory capacity was associated with inflammation in the exposed neonates.
What are the greatest implications of this study?
The findings suggest that elevated inflammation in HIV-exposed but uninfected neonates may stem in part from a weakened capacity of maternal breast milk IgA to control specific commensal bacteria such as Blautia coccoides. This points to a potential antibody-mediated mechanism linking maternal HIV status, infant gut microbiota composition, and systemic inflammation in the infant. Understanding this pathway could inform strategies to support healthy immune development in this vulnerable population.